N-Boc-sarcosine methyl ester, 95.0%, 10g

(2-Morpholin-2-yl-ethyl)-carbamic acid tert-butylester, 95.0%, 1g

Microliter syringe MICROLITER® series 700 Point type 3, 100 µl, 710 NR, 1 piece

tert-Butyl ((3S,5S)-5-(trifluoromethyl)piperidin-3-yl)carbamate, 98%, 250mg

(R)-3-(Boc-amino)-2-oxo-1-pyrrolidine-acetic acid, 99.0%, 250mg

(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dimethoxyphenyl)propanoic acid, 98%, 250mg

(5-Bromo-2-fluoro-4-(trifluoromethyl)phenyl)methanol, 98%, 500mg

(R)-methyl 3-bromo-2-((tert-butoxycarbonyl)amino)propanoate, 98%, 100mg

(3aR,3a'R,8aS,8a'S)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole), 98.0%, 5g

Standard ladles ROTILABO®, 80 ml, , 70 mm, 290 mm, 1 Piece

Methyl-4-methoxy-1-naphthoate, 97%, 2g

(3-Bromothiophen-2-yl)methanamine hydrochloride, 95+%, 25g

Ginsenoside-Rb1, ROTI®STAR Primary Standard, 10 mg, glass packaging